Showing 11,021 - 11,040 results of 226,405 for search '(( a ((((laser decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a larger decrease ))', query time: 1.83s Refine Results
  1. 11021
  2. 11022

    S1A Fig raw image. by Rachel K. Meade (22216529)

    Published 2025
    “…Here, we identify cathepsin Z (<i><i>Ctsz</i></i>) as a lead candidate underlying this TB susceptibility and show that <i><i>Ctsz</i></i> ablation leads to increased bacterial burden, pulmonary inflammation and decreased survival in mice. …”
  3. 11023

    Behavioural data from Study A. by Jasmine Heurlin (18501279)

    Published 2024
    “…In addition, human walking positively influenced eye contact behaviour while simultaneously decreasing exploration behaviour. In study C, a group of six socialised pack-living wolves and six similarly socialised pack-living dogs were tested after the <i>Ignore</i> treatment. …”
  4. 11024

    Establishment of a diabetic rat model. by Lan Zeng (638254)

    Published 2025
    “…In addition, RP11-502I4.3 expression was decreased in the retinas of diabetic rats compared with non-diabetic rats (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0312791#pone.0312791.g003" target="_blank">Fig 3B</a>), and it was predominantly localised in the cytoplasm (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0312791#pone.0312791.g003" target="_blank">Fig 3C</a>).…”
  5. 11025
  6. 11026

    S4 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  7. 11027

    S1 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  8. 11028

    S5 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  9. 11029

    S3 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  10. 11030

    S6 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  11. 11031

    Input parameters for the base-case analysis. by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  12. 11032

    S2 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  13. 11033

    S1 Data - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  14. 11034
  15. 11035
  16. 11036
  17. 11037
  18. 11038
  19. 11039
  20. 11040